Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 168

Similar articles for PubMed (Select 17694086)

1.

Class IIa histone deacetylases: regulating the regulators.

Martin M, Kettmann R, Dequiedt F.

Oncogene. 2007 Aug 13;26(37):5450-67. Review.

PMID:
17694086
2.

The emerging role of class II histone deacetylases.

Fischle W, Kiermer V, Dequiedt F, Verdin E.

Biochem Cell Biol. 2001;79(3):337-48. Review.

PMID:
11467747
3.

Class II histone deacetylases: structure, function, and regulation.

Bertos NR, Wang AH, Yang XJ.

Biochem Cell Biol. 2001;79(3):243-52. Review.

PMID:
11467738
4.

Class IIa histone deacetylases: conducting development and differentiation.

Martin M, Kettmann R, Dequiedt F.

Int J Dev Biol. 2009;53(2-3):291-301. doi: 10.1387/ijdb.082698mm. Review.

5.

Histone deacetylases--an important class of cellular regulators with a variety of functions.

Hildmann C, Riester D, Schwienhorst A.

Appl Microbiol Biotechnol. 2007 Jun;75(3):487-97. Epub 2007 Mar 22. Review.

PMID:
17377789
6.

Determination of protein lysine deacetylation.

Ellis DJ, Yuan Z, Seto E.

Curr Protoc Protein Sci. 2008 Nov;Chapter 14:Unit 14.12. doi: 10.1002/0471140864.ps1412s54.

PMID:
19016433
7.

NAD+-dependent deacetylation of H4 lysine 16 by class III HDACs.

Vaquero A, Sternglanz R, Reinberg D.

Oncogene. 2007 Aug 13;26(37):5505-20. Review.

PMID:
17694090
8.

Protein deacetylases: enzymes with functional diversity as novel therapeutic targets.

Yoshida M, Shimazu T, Matsuyama A.

Prog Cell Cycle Res. 2003;5:269-78. Review.

PMID:
14593721
9.

The structure and function of histone deacetylases: the target for anti-cancer therapy.

Zhang Y, Fang H, Jiao J, Xu W.

Curr Med Chem. 2008;15(27):2840-9. Review.

PMID:
18991639
10.
11.

Class II histone deacetylases: versatile regulators.

Verdin E, Dequiedt F, Kasler HG.

Trends Genet. 2003 May;19(5):286-93. Review.

PMID:
12711221
12.

Members of the histone deacetylase superfamily differ in substrate specificity towards small synthetic substrates.

Riester D, Wegener D, Hildmann C, Schwienhorst A.

Biochem Biophys Res Commun. 2004 Nov 19;324(3):1116-23.

PMID:
15485670
13.

Histone deacetylase inhibitors in cancer therapy: latest developments, trends and medicinal chemistry perspective.

Balakin KV, Ivanenkov YA, Kiselyov AS, Tkachenko SE.

Anticancer Agents Med Chem. 2007 Sep;7(5):576-92. Review.

PMID:
17896917
14.

Histone deacetylases: salesmen and customers in the post-translational modification market.

Brandl A, Heinzel T, Krämer OH.

Biol Cell. 2009 Apr;101(4):193-205. doi: 10.1042/BC20080158. Review.

PMID:
19207105
15.

The role of histone deacetylases (HDACs) in human cancer.

Ropero S, Esteller M.

Mol Oncol. 2007 Jun;1(1):19-25. doi: 10.1016/j.molonc.2007.01.001. Epub 2007 Mar 7. Review.

16.

Identification of the ankyrin repeat proteins ANKRA and RFXANK as novel partners of class IIa histone deacetylases.

Wang AH, Grégoire S, Zika E, Xiao L, Li CS, Li H, Wright KL, Ting JP, Yang XJ.

J Biol Chem. 2005 Aug 12;280(32):29117-27. Epub 2005 Jun 17.

17.

HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics.

Gallinari P, Di Marco S, Jones P, Pallaoro M, Steinkühler C.

Cell Res. 2007 Mar;17(3):195-211. Review.

18.

Nuclear histone deacetylases are not required for global histone deacetylation during meiotic maturation in porcine oocytes.

Endo T, Kano K, Naito K.

Biol Reprod. 2008 Jun;78(6):1073-80. doi: 10.1095/biolreprod.107.067397. Epub 2008 Feb 27.

19.

Histone tail modifications and noncanonical functions of histones: perspectives in cancer epigenetics.

Hadnagy A, Beaulieu R, Balicki D.

Mol Cancer Ther. 2008 Apr;7(4):740-8. doi: 10.1158/1535-7163.MCT-07-2284. Review.

20.

Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases.

Somoza JR, Skene RJ, Katz BA, Mol C, Ho JD, Jennings AJ, Luong C, Arvai A, Buggy JJ, Chi E, Tang J, Sang BC, Verner E, Wynands R, Leahy EM, Dougan DR, Snell G, Navre M, Knuth MW, Swanson RV, McRee DE, Tari LW.

Structure. 2004 Jul;12(7):1325-34.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk